Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Raphael Niklaus Sieber"'
Autor:
Frederik Plesner Lyngse, Laust Hvas Mortensen, Matthew J. Denwood, Lasse Engbo Christiansen, Camilla Holten Møller, Robert Leo Skov, Katja Spiess, Anders Fomsgaard, Ria Lassaunière, Morten Rasmussen, Marc Stegger, Claus Nielsen, Raphael Niklaus Sieber, Arieh Sierra Cohen, Frederik Trier Møller, Maria Overvad, Kåre Mølbak, Tyra Grove Krause, Carsten Thure Kirkeby
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
In this study, the authors compare the transmission dynamics of the Delta and Omicron SARS-CoV-2 variants using household data from Denmark. They find that Omicron has a higher secondary attack rate, and that the odds of infection with Omicron was hi
Externí odkaz:
https://doaj.org/article/339f2910e1db43cda719838728936f31
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark
Autor:
Frederik Plesner Lyngse, Carsten Thure Kirkeby, Matthew Denwood, Lasse Engbo Christiansen, Kåre Mølbak, Camilla Holten Møller, Robert Leo Skov, Tyra Grove Krause, Morten Rasmussen, Raphael Niklaus Sieber, Thor Bech Johannesen, Troels Lillebaek, Jannik Fonager, Anders Fomsgaard, Frederik Trier Møller, Marc Stegger, Maria Overvad, Katja Spiess, Laust Hvas Mortensen
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
In this study, the authors use household data from Denmark to investigate the transmissibility of the BA.1 and BA.2 Omicron SARS-CoV-2 subvariants. They find that the secondary attack rate was higher for BA.2, but that it had higher infectiousness on
Externí odkaz:
https://doaj.org/article/63e8f6a41a2647f08679c3a294ba34cf
Autor:
Frederik Plesner Lyngse, Kåre Mølbak, Matt Denwood, Lasse Engbo Christiansen, Camilla Holten Møller, Morten Rasmussen, Arieh Sierra Cohen, Marc Stegger, Jannik Fonager, Raphael Niklaus Sieber, Kirsten Maren Ellegaard, Claus Nielsen, Carsten Thure Kirkeby
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-8 (2022)
COVID-19 vaccines may reduce the susceptibility of an individual to infection and/or the infectiousness of breakthrough infections. Here, the authors use data from Denmark and estimate that vaccine effectiveness was 61% for susceptibility and 31% for
Externí odkaz:
https://doaj.org/article/d84e9926f5eb4541bccf618d13e3d9d4
Autor:
Mie Agermose Gram, Hanne-Dorthe Emborg, Astrid Blicher Schelde, Nikolaj Ulrik Friis, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Rebecca Legarth, Janni Uyen Hoa Lam, Manon Chaine, Aisha Zahoor Malik, Morten Rasmussen, Jannik Fonager, Raphael Niklaus Sieber, Marc Stegger, Steen Ethelberg, Palle Valentiner-Branth, Christian Holm Hansen
Publikováno v:
PLoS Medicine, Vol 19, Iss 9, p e1003992 (2022)
BackgroundThe continued occurrence of more contagious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants and waning immunity over time require ongoing reevaluation of the vaccine effectiveness (VE). This study aimed to estimate the
Externí odkaz:
https://doaj.org/article/f5d56dceedce45b8bdf925dd9ea08d10
Autor:
Peter Bager, Jan Wohlfahrt, Samir Bhatt, Marc Stegger, Rebecca Legarth, Camilla Holten Møller, Robert Leo Skov, Palle Valentiner-Branth, Marianne Voldstedlund, Thea K Fischer, Lone Simonsen, Nikolai Søren Kirkby, Marianne Kragh Thomsen, Katja Spiess, Ellinor Marving, Nicolai Balle Larsen, Troels Lillebaek, Henrik Ullum, Kåre Mølbak, Tyra Grove Krause, Sofie Marie Edslev, Raphael Niklaus Sieber, Anna Cäcilia Ingham, Maria Overvad, Mie Agermose Gram, Frederikke Kristensen Lomholt, Louise Hallundbæk, Caroline Hjorth Espensen, Sophie Gubbels, Marianne Karakis, Karina Lauenborg Møller, Stefan Schytte Olsen, Zitta Barrella Harboe, Caroline Klint Johannesen, Maarten van Wijhe, Jon Gitz Holler, Ram Benny Christian Dessau, Martin Barfred Friis, David Fuglsang-Damgaard, Mette Pinholt, Thomas Vognbjerg Sydenham, John Eugenio Coia, Ea Sofie Marmolin, Anders Fomsgaard, Jannik Fonager, Morten Rasmussen, Arieh Cohen
Publikováno v:
Bager, P, Wohlfahrt, J, Bhatt, S, Stegger, M, Legarth, R, Møller, C H, Skov, R L, Valentiner-Branth, P, Voldstedlund, M, Fischer, T K, Simonsen, L, Kirkby, N S, Thomsen, M K, Spiess, K, Marving, E, Larsen, N B, Lillebaek, T, Ullum, H, Mølbak, K, Krause, T G & the Omicron-Delta study group 2022, ' Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark : an observational cohort study ', The Lancet Infectious Diseases, vol. 22, no. 7, pp. 967-976 . https://doi.org/10.1016/S1473-3099(22)00154-2
Background: Estimates of the severity of the SARS-CoV-2 omicron variant (B.1.1.529) are crucial to assess the public health impact associated with its rapid global dissemination. We estimated the risk of SARS-CoV-2-related hospitalisations after infe
Publikováno v:
The Journal of antimicrobial chemotherapy.
BackgroundDalbavancin, a semisynthetic lipoglycopeptide with exceptionally long half-life and Gram-positive spectrum, is an attractive option for infections requiring prolonged therapy, including prosthetic joint infections (PJIs).ObjectivesTo invest
Autor:
Mie Agermose Gram, Hanne-Dorthe Emborg, Astrid Blicher Schelde, Nikolaj Ulrik Friis, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Rebecca Legarth, Janni Uyen Hoa Lam, Manon Chaine, Aisha Zahoor Malik, Morten Rasmussen, Jannik Fonager, Raphael Niklaus Sieber, Marc Stegger, Steen Ethelberg, Palle Valentiner-Branth, Christian Holm Hansen
BackgroundThe continued occurrence of more contagious SARS-CoV-2 variants and waning immunity over time require ongoing re-evaluation of the vaccine effectiveness (VE). This study aimed to estimate the effectiveness in two age groups (12-59 and 60 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46937caf58a4db41b952f69ea2acd17d
https://doi.org/10.1101/2022.04.20.22274061
https://doi.org/10.1101/2022.04.20.22274061
Autor:
Jannik Fonager, Marc Bennedbæk, Peter Bager, Jan Wohlfahrt, Kirsten Maren Ellegaard, Anna Cäcilia Ingham, Sofie Marie Edslev, Marc Stegger, Raphael Niklaus Sieber, Ria Lassauniere, Anders Fomsgaard, Troels Lillebaek, Christina Wiid Svarrer, Frederik Trier Møller, Camilla Holten Møller, Rebecca Legarth, Thomas Vognbjerg Sydenham, Kat Steinke, Sarah Juel Paulsen, José Alfredo Samaniego Castruita, Uffe Vest Schneider, Christian Højte Schouw, Xiaohui Chen Nielsen, Maria Overvad, Rikke Thoft Nielsen, Rasmus L Marvig, Martin Schou Pedersen, Lene Nielsen, Line Lynge Nilsson, Jonas Bybjerg-Grauholm, Irene Harder Tarpgaard, Tine Snejbjerg Ebsen, Janni Uyen Hoa Lam, Vithiagaran Gunalan, Morten Rasmussen
Publikováno v:
Fonager, J, Bennedbæk, M, Bager, P, Wohlfahrt, J, Ellegaard, K M, Ingham, A C, Edslev, S M, Stegger, M, Sieber, R N, Lassauniere, R, Fomsgaard, A, Lillebaek, T, Svarrer, C W, Møller, F T, Møller, C H, Legarth, R, Sydenham, T V, Steinke, K, Paulsen, S J, Castruita, J A S, Schneider, U V, Schouw, C H, Nielsen, X C, Overvad, M, Nielsen, R T, Marvig, R L, Pedersen, M S, Nielsen, L, Nilsson, L L, Bybjerg-Grauholm, J, Tarpgaard, I H, Ebsen, T S, Lam, J U H, Gunalan, V & Rasmussen, M 2022, ' Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022 ', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 27, no. 10 . https://doi.org/10.2807/1560-7917.ES.2022.27.10.2200181
Fonager, J, Bennedbæk, M, Bager, P, Wohlfahrt, J, Ellegaard, K M, Ingham, A C, Edslev, S M, Stegger, M, Sieber, R N, Lassauniere, R, Fomsgaard, A, Lillebaek, T, Svarrer, C W, Møller, F T, Møller, C H, Legarth, R, Sydenham, T V, Steinke, K, Paulsen, S J, Castruita, J A S, Schneider, U V, Schouw, C H, Nielsen, X C, Overvad, M, Nielsen, R T, Marvig, R L, Pedersen, M S, Nielsen, L, Nilsson, L L, Bybjerg-Grauholm, J, Tarpgaard, I H, Ebsen, T S, Lam, J U H, Gunalan, V & Rasmussen, M 2022, ' Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022 ', Eurosurveillance, vol. 27, no. 10, pii=220018 . https://doi.org/10.2807/1560-7917.ES.2022.27.10.2200181
Fonager, J, Bennedbæk, M, Bager, P, Wohlfahrt, J, Ellegaard, K M, Ingham, A C, Edslev, S M, Stegger, M, Sieber, R N, Lassauniere, R, Fomsgaard, A, Lillebaek, T, Svarrer, C W, Møller, F T, Møller, C H, Legarth, R, Sydenham, T V, Steinke, K, Paulsen, S J, Castruita, J A S, Schneider, U V, Schouw, C H, Nielsen, X C, Overvad, M, Nielsen, R T, Marvig, R L, Pedersen, M S, Nielsen, L, Nilsson, L L, Bybjerg-Grauholm, J, Tarpgaard, I H, Ebsen, T S, Lam, J U H, Gunalan, V & Rasmussen, M 2022, ' Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022 ', Eurosurveillance, vol. 27, no. 10, pii=220018 . https://doi.org/10.2807/1560-7917.ES.2022.27.10.2200181
Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first 2,623 BA.2 cases from 29 November 2021 to 2 January 2022. No epidemiological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629f707750068982d48d56aeed153e91
https://pure.au.dk/portal/da/publications/molecular-epidemiology-of-the-sarscov2-variant-omicron-ba2-sublineage-in-denmark-29-november-2021-to-2-january-2022(1ecec5a3-6b82-4b1c-bd6b-95bd74c739a8).html
https://pure.au.dk/portal/da/publications/molecular-epidemiology-of-the-sarscov2-variant-omicron-ba2-sublineage-in-denmark-29-november-2021-to-2-january-2022(1ecec5a3-6b82-4b1c-bd6b-95bd74c739a8).html
Autor:
Marc Stegger, Sofie Marie Edslev, Raphael Niklaus Sieber, Anna Cäcilia Ingham, Kim Lee Ng, Man-Hung Eric Tang, Soren Alexandersen, Jannik Fonager, Rebecca Legarth, Magdalena Utko, Bartlomiej Wilkowski, Vithiagaran Gunalan, Marc Bennedbæk, Jonas Byberg-Grauholm, Camilla Holten Møller, Lasse Engbo Christiansen, Christina Wiid Svarrer, Kirsten Ellegaard, Sharmin Baig, Thor Bech Johannesen, Laura Espenhain, Robert Skov, Arieh Sierra Cohen, Nicolai Balle Larsen, Karina Meden Sørensen, Emily Dibba White, Troels Lillebaek, Henrik Ullum, Tyra Grove Krause, Anders Fomsgaard, Steen Ethelberg, Morten Rasmussen
The newly found Omicron SARS-CoV-2 variant of concern has rapidly spread worldwide. Omicron carries numerous mutations in key regions and is associated with increased transmissibility and immune escape. The variant has recently been divided into four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3267c119a3756d0b013b9f53a870138
https://doi.org/10.1101/2022.02.19.22271112
https://doi.org/10.1101/2022.02.19.22271112
Autor:
Frederik Plesner Lyngse, Carsten Thure Kirkeby, Matthew Denwood, Lasse Engbo Christiansen, Kåre Mølbak, Camilla Holten Møller, Robert Leo Skov, Tyra Grove Krause, Morten Rasmussen, Raphael Niklaus Sieber, Thor Bech Johannesen, Troels Lillebaek, Jannik Fonager, Anders Fomsgaard, Frederik Trier Møller, Marc Stegger, Maria Overvad, Katja Spiess, Laust Hvas Mortensen
1AbstractThe Omicron SARS-CoV-2 variant of concern (VOC lineage B.1.1.529), which became dominant in many countries during early 2022, includes several subvariants with strikingly different genetic characteristics. Several countries, including Denmar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4a780a594347cae4ca20beda6b19c09
https://doi.org/10.1101/2022.01.28.22270044
https://doi.org/10.1101/2022.01.28.22270044